News Sentiment

OABI sentiment intelligence

OmniAb Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 53 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.29 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-5.4% over one week, +0.9% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

OmniAb Names Amechi Nwachuku Chief Operating Officer

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction -5.4% Price reacting lower
Trend fit Trend active 0.9% over four weeks
Fair value -32.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 32
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 46
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
TradingView 9
www.marketscreener.com 3
Stock Titan 3
simplywall.st 3
Investing.com 2
dars.gov.et 2
Finviz 2

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 23
Analyst action 2
Guidance 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 54
Nasdaq Direct company coverage

OmniAb Names Amechi Nwachuku Chief Operating Officer

OmniAb, Inc. (NASDAQ:OABI) has appointed Amechi Nwachuku as its new Executive Vice President and Chief Operating Officer, effective immediately. Nwachuku brings over 25 years of experience in leading global life sciences tools businesses and will primarily manage the strategy and

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 08:42
Source
Nasdaq
Investing.com Direct company coverage

OmniAb appoints Amechi Nwachuku as chief operating officer

OmniAb, Inc. (NASDAQ:OABI) has appointed Amechi Nwachuku as Executive Vice President and Chief Operating Officer, a new role focused on strategy, operations, and commercial aspects of its xPloration platform. Nwachuku brings over 25 years of experience in life sciences and has he

Tone
Positive 72/100
Event
Market update
Published
13 Jul 2026 20:44
Source
Investing.com
Minichart Direct company coverage

OmniAb, Inc. Appoints Amechi Nwachuku as Chief Operating Officer – Leadership Update July 2026

OmniAb, Inc. has filed a routine Form 8-K with the SEC on July 13, 2026, which does not contain any price-sensitive or material news. The filing updates standard company and security information but discloses no new operational, financial, strategic developments, or changes in di

Tone
Neutral 50/100
Event
Market update
Published
13 Jul 2026 16:12
Source
Minichart
www.marketscreener.com Direct company coverage

Omniab, Inc. Announces Appointment of Amechi Nwachuku to Executive Vice President and Chief Operating Officer, Effective July 13, 2026

OmniAb, Inc. has appointed Amechi Nwachuku as its new Executive Vice President and Chief Operating Officer, effective July 13, 2026. Nwachuku brings over two decades of global life sciences leadership experience from companies including Thermo Fisher Scientific, Danaher's SCIEX a

Tone
Positive 67/100
Event
Market update
Published
13 Jul 2026 15:12
Source
www.marketscreener.com
Contract Pharma Direct company coverage

OmniAb Taps Amechi Nwachuku as Executive Vice President & Chief Operating Officer

OmniAb Inc. has appointed Amechi Nwachuku as its new Executive Vice President and Chief Operating Officer (COO). In this role, Nwachuku will be responsible for overseeing the strategy, operations, and commercial maximization of OmniAb’s xPloration platform. He brings over 25 year

Tone
Neutral 50/100
Event
Market update
Published
13 Jul 2026 15:12
Source
Contract Pharma
citybiz Direct company coverage

OmniAb Appoints Amechi Nwachuku COO to Expand xPloration Platform Commercialization

OmniAb Inc. (NASDAQ: OABI) has appointed Amechi Nwachuku as Executive Vice President and Chief Operating Officer to lead the strategy, operations, and commercial expansion of its xPloration® antibody discovery platform. Nwachuku brings over 25 years of experience in life sciences

Tone
Positive 74/100
Event
Market update
Published
13 Jul 2026 13:12
Source
citybiz
TradingView Direct company coverage

Amechi Nwachuku named COO at OmniAb with stock options and severance

OmniAb has appointed Amechi Nwachuku as Chief Operating Officer, effective July 13, 2026. His compensation package includes an initial annual base salary of $445,000, a target bonus of 45% of base salary, and a grant of options to purchase 800,000 shares. Nwachuku is also eligibl

Tone
Positive 65/100
Event
Analyst action
Published
13 Jul 2026 12:12
Source
TradingView
Finviz Direct company coverage

OABI,VKTX Revenue Breakdown

This article provides a financial overview and key performance indicators for two biotechnology companies: OmniAb Inc. (OABI) and Viking Therapeutics Inc. (VKTX). It details their market capitalization, income, sales, various financial ratios, stock performance, and analyst recom

Tone
Neutral 50/100
Event
Earnings
Published
07 Jul 2026 06:41
Source
Finviz
MSN Direct company coverage

OmniAb (OABI) Price Target Decreased by 13.73% to 7.48

The article reports that the price target for OmniAb (OABI) has been decreased by 13.73%, bringing the new target to $7.48. This information solely focuses on the updated financial outlook for the company's stock.

Tone
Negative 29/100
Event
Guidance
Published
05 Jul 2026 07:09
Source
MSN
Finviz Direct company coverage

OABI - OmniAb Inc Volatility & Greeks

This article provides a detailed financial overview of OmniAb Inc (OABI), including its stock performance metrics, volatility, and various financial ratios. It lists key data such as market capitalization, income, sales, and per-share values, alongside insider ownership, institut

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 17:40
Source
Finviz
Insider Monkey Direct company coverage

OmniAb (OABI) Gains More Than 38% Over 6 Months, Can It Go Higher?

OmniAb, Inc. (NASDAQ: OABI) has seen significant gains, rising over 38% in the past six months and 74% since its Q1 2026 earnings release. The company's revenue surged from $4.2 million to $14.4 million in Q1 2026, driven by milestone payments, while R&D and G&A costs decreased,

Tone
Positive 70/100
Event
Earnings
Published
03 Jul 2026 09:13
Source
Insider Monkey
TradingView Direct company coverage

OmniAb, Inc. Warrant 2022- on Omniab Inc Financial Disclosures & SEC Filings

This article provides a comprehensive listing of OmniAb, Inc.'s financial disclosures and SEC filings, including quarterly and annual earnings reports, 8-Ks, 10-Qs, and 10-Ks. It details corporate events, investor updates, and press releases, offering insights into the company's

Tone
Neutral 50/100
Event
Earnings
Published
02 Jul 2026 09:39
Source
TradingView
TradingView Direct company coverage

OmniAb, Inc. Financial Disclosures & SEC Filings

This article provides a comprehensive list of OmniAb, Inc.'s financial disclosures and SEC filings, including earnings reports (Forms 10-K, 10-Q, 8-K), corporate presentations, and investor updates stretching from Q1 2026 back to Q4 2021. It details key highlights for each filing

Tone
Positive 63/100
Event
Earnings
Published
01 Jul 2026 22:10
Source
TradingView
marketscreener.com Direct company coverage

OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 2500 Growth Benchmark

OmniAb, Inc. (NasdaqGM: OABI) has been dropped from the Russell 2500 Growth Benchmark, a decision officially published on June 29, 2026. This exclusion is part of a broader removal from several Russell benchmarks, including the Russell Microcap Growth, Russell 2000 Growth, Russel

Tone
Negative 34/100
Event
Market update
Published
29 Jun 2026 19:58
Source
marketscreener.com
Moomoo Direct company coverage

Earnings Preview: OmniAb to Report Financial Results Post-market on May 07

OmniAb is scheduled to report its financial results after market close on May 07. This earnings preview indicates that investors and analysts will be closely watching the company's performance. The results will provide insight into the company's financial health and future outloo

Tone
Neutral 50/100
Event
Earnings
Published
29 Jun 2026 12:39
Source
Moomoo
www.marketscreener.com Direct company coverage

OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 2000 Growth Benchmark

OmniAb, Inc. (NasdaqGM: OABI) has been removed from the Russell 2000 Growth Benchmark. This news follows earlier reports of its removal from the Russell Microcap Growth Benchmark Index and the Russell 3000E Growth Benchmark. OmniAb specializes in licensing discovery research tech

Tone
Negative 29/100
Event
Market update
Published
29 Jun 2026 07:27
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 3000 Growth Benchmark

OmniAb, Inc. (NasdaqGM: OABI) has been dropped from the Russell 3000 Growth Benchmark. This move follows a series of similar announcements where the company was removed from other Russell indices, including the Russell 2500, Microcap, 2000, 3000E Growth, and Small Cap Comp Growth

Tone
Negative 29/100
Event
Market update
Published
28 Jun 2026 18:11
Source
www.marketscreener.com
TradingView Direct company coverage

Enterprise value to revenue forward of OmniAb, Inc. – BOATS:OABIW

This article provides financial information for OmniAb, Inc. under the ticker OABIW, focusing on its enterprise value to revenue forward. It appears to be a financial data page from TradingView, offering an overview of the company's financials without detailed analysis. The conte

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 19:39
Source
TradingView
TradingView Direct company coverage

OABI Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for OmniAb, Inc. (OABI) stock, including analyst opinions, historical price performance, and financial metrics. It highlights key data such as the current stock price, market capitalization, earnings reports, and volatility, while

Tone
Positive 63/100
Event
Analyst action
Published
26 Jun 2026 01:41
Source
TradingView
TradingView Direct company coverage

Price to book forward of OmniAb, Inc. – BOATS:OABIW

This page provides financial information for OmniAb, Inc. (OABIW), specifically focusing on its price to book forward ratio. The data is presented through TradingView, noting that the market is currently closed with no trades.

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 01:41
Source
TradingView
TradingView Direct company coverage

OmniAb, Inc. Actuals & Estimates (NASDAQ:OABI)

This article provides an overview of OmniAb, Inc. (NASDAQ: OABI) stock performance, financial actuals, and analyst estimates. It covers various metrics including current stock price, market capitalization, earnings, revenue, and future forecasts, offering insights into the compan

Tone
Positive 59/100
Event
Earnings
Published
26 Jun 2026 00:40
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of OmniAb, Inc. – BOATS:OABIW

This article provides financial information for OmniAb, Inc. under the ticker symbol OABIW on the Blue Ocean Alternative Trade System (BOATS). It specifically highlights the "Price to earnings forward" metric. The content appears to be a financial data page from TradingView, show

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 17:39
Source
TradingView
TradingKey Direct company coverage

OmniAb Inc (OABI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of OmniAb Inc (OABI), detailing its price momentum score of 8.80 in the Biotechnology & Medical Research industry, trading between resistance at $2.87 and support at $2.08. It evaluates various technical indicators like MACD, RSI, and mo

Tone
Positive 67/100
Event
Market update
Published
24 Jun 2026 13:40
Source
TradingKey
Investing.com Nigeria Direct company coverage

OmniAb shareholders elect directors and ratify auditor at annual meeting By Investing.com

OmniAb, Inc. (NASDAQ:OABI) held its 2026 Annual Meeting where shareholders elected Jennifer Cochran, Ph.D., and Matthew W. Foehr as Class I directors for three-year terms. Additionally, Ernst & Young LLP was ratified as the independent registered public accounting firm for the fi

Tone
Positive 61/100
Event
Market update
Published
19 Jun 2026 02:40
Source
Investing.com Nigeria